Skip to main content
. 2017 Jul 31;8(48):83817–83830. doi: 10.18632/oncotarget.19745

B.

Effects Event(GF)/total p value
Patient age at transplant
 <15 yr 0/49 0.019
 ≥15 yr 3/28
Diagnosis-to-transplant interval
 ≤6 months 0/38 0.081
 >6 months 3/39
IST prior to referral for HSCT
 ATG included 0/15 0.385
 ATG excluded 3/62
Transfusion RBC before HSCT
 ≥25U 2/29 0.290
 <25U 1/48
Infused MNC cells
 ≤8×108/kg 2/11 0.008
 >8×108/kg 1/66
Infused CD34+ cells 0.001
 ≤3×106/kg 3/14
 >3×106/kg 0/63
Conditioning regimen 0.667
 A(Flu+Cy+ATG+Bu) 2/42
 B(Flu+Cy+ATG) 1/35
Donor age 0.001
 <45 yr 0/65
 ≥45 yr 3/12
D-R sex match 0.290
 Match 1/48
 Mismatch 2/29
D-R major blood group match 0.700
 Match 2/43
 Mismatch 1/34
D-R HLA mismatched 0.341
 2-4 HLA loci 2/31
 5 HLA loci 1/46

(A) Clinical data and outcome of three patients with GR or GF. (B) Comparison of effects of different variables on GF of patients after transplantation.

GF, graft failure; GR, graft rejection.

D-R, donor-recipient.